A randomized controlled trial of weight reduction as a treatment for breast cancer-related lymphedema
Identifieur interne : 000486 ( PascalFrancis/Checkpoint ); précédent : 000485; suivant : 000487A randomized controlled trial of weight reduction as a treatment for breast cancer-related lymphedema
Auteurs : Clare Shaw [Royaume-Uni] ; Peter Mortimer (dermatologue) [Royaume-Uni] ; Patricia A. Judd [Royaume-Uni]Source :
- Cancer [ 0008-543X ] ; 2007.
Descripteurs français
- Pascal (Inist)
- Wicri :
- topic : Nutrition.
English descriptors
- KwdEn :
Abstract
BACKGROUND. Obesity is considered a risk factor for the development of breast cancer-related lymphedema of the arm and as a poor prognostic factor in response to lymphedema treatment. The objective of this study was to examine weight reduction as a treatment for breast cancer-related lymphedema. METHODS. Twenty-one women with breast cancer-related lymphedema were randomized either to receive dietary advice for weight reduction or to receive a booklet on general healthy eating. They were monitored for 12 weeks. RESULTS. The primary outcome measure was arm volume at 12 weeks. The results indicated a significant reduction in swollen arm volume at the end of the 12-week period (P =.003) in the intervention weight-reduction group. There was a significant reduction in body weight (P =.02) and body mass index (P =.016) in the weight-reduction group at the end of the 12-week study period. CONCLUSIONS. Weight loss achieved by dietary advice to reduce energy intake can reduce breast cancer-related lymphedema significantly.
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
Pascal:07-0473188Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">A randomized controlled trial of weight reduction as a treatment for breast cancer-related lymphedema</title>
<author><name sortKey="Shaw, Clare" sort="Shaw, Clare" uniqKey="Shaw C" first="Clare" last="Shaw">Clare Shaw</name>
<affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Department of Nutrition and Dietetics, Royal Marsden National Health Service Foundation Trust</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
<placeName><settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Mortimer, Peter" sort="Mortimer, Peter" uniqKey="Mortimer P" first="Peter" last="Mortimer">Peter Mortimer (dermatologue)</name>
<affiliation wicri:level="3"><inist:fA14 i1="02"><s1>Dermatological Medicine, Royal Marsden National Health Service Foundation Trust</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
<placeName><settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
<placeName><settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
<orgName type="university">Université de Londres</orgName>
</affiliation>
</author>
<author><name sortKey="Judd, Patricia A" sort="Judd, Patricia A" uniqKey="Judd P" first="Patricia A." last="Judd">Patricia A. Judd</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Nutrition and Dietetics, Lancashire School of Health and Postgraduate Medicine, University of Central Lancashire</s1>
<s2>Preston, Lancashire</s2>
<s3>GBR</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
<wicri:noRegion>Preston, Lancashire</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">07-0473188</idno>
<date when="2007">2007</date>
<idno type="stanalyst">PASCAL 07-0473188 INIST</idno>
<idno type="RBID">Pascal:07-0473188</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000431</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000529</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000486</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000486</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">A randomized controlled trial of weight reduction as a treatment for breast cancer-related lymphedema</title>
<author><name sortKey="Shaw, Clare" sort="Shaw, Clare" uniqKey="Shaw C" first="Clare" last="Shaw">Clare Shaw</name>
<affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Department of Nutrition and Dietetics, Royal Marsden National Health Service Foundation Trust</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
<placeName><settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Mortimer, Peter" sort="Mortimer, Peter" uniqKey="Mortimer P" first="Peter" last="Mortimer">Peter Mortimer (dermatologue)</name>
<affiliation wicri:level="3"><inist:fA14 i1="02"><s1>Dermatological Medicine, Royal Marsden National Health Service Foundation Trust</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
<placeName><settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
<placeName><settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
<orgName type="university">Université de Londres</orgName>
</affiliation>
</author>
<author><name sortKey="Judd, Patricia A" sort="Judd, Patricia A" uniqKey="Judd P" first="Patricia A." last="Judd">Patricia A. Judd</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Nutrition and Dietetics, Lancashire School of Health and Postgraduate Medicine, University of Central Lancashire</s1>
<s2>Preston, Lancashire</s2>
<s3>GBR</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
<wicri:noRegion>Preston, Lancashire</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Cancer</title>
<title level="j" type="abbreviated">Cancer</title>
<idno type="ISSN">0008-543X</idno>
<imprint><date when="2007">2007</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Cancer</title>
<title level="j" type="abbreviated">Cancer</title>
<idno type="ISSN">0008-543X</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Breast cancer</term>
<term>Cancerology</term>
<term>Diet</term>
<term>Lymphedema</term>
<term>Nutrition</term>
<term>Randomised controlled trial</term>
<term>Treatment</term>
<term>Weight</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Lymphoedème</term>
<term>Poids</term>
<term>Traitement</term>
<term>Régime alimentaire</term>
<term>Nutrition</term>
<term>Cancérologie</term>
<term>Essai randomisé contrôlé</term>
<term>Cancer du sein</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Nutrition</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">BACKGROUND. Obesity is considered a risk factor for the development of breast cancer-related lymphedema of the arm and as a poor prognostic factor in response to lymphedema treatment. The objective of this study was to examine weight reduction as a treatment for breast cancer-related lymphedema. METHODS. Twenty-one women with breast cancer-related lymphedema were randomized either to receive dietary advice for weight reduction or to receive a booklet on general healthy eating. They were monitored for 12 weeks. RESULTS. The primary outcome measure was arm volume at 12 weeks. The results indicated a significant reduction in swollen arm volume at the end of the 12-week period (P =.003) in the intervention weight-reduction group. There was a significant reduction in body weight (P =.02) and body mass index (P =.016) in the weight-reduction group at the end of the 12-week study period. CONCLUSIONS. Weight loss achieved by dietary advice to reduce energy intake can reduce breast cancer-related lymphedema significantly.</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0008-543X</s0>
</fA01>
<fA02 i1="01"><s0>CANCAR</s0>
</fA02>
<fA03 i2="1"><s0>Cancer</s0>
</fA03>
<fA05><s2>110</s2>
</fA05>
<fA06><s2>8</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>A randomized controlled trial of weight reduction as a treatment for breast cancer-related lymphedema</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>SHAW (Clare)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>MORTIMER (Peter)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>JUDD (Patricia A.)</s1>
</fA11>
<fA14 i1="01"><s1>Department of Nutrition and Dietetics, Royal Marsden National Health Service Foundation Trust</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>Dermatological Medicine, Royal Marsden National Health Service Foundation Trust</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>2 aut.</sZ>
</fA14>
<fA14 i1="03"><s1>Nutrition and Dietetics, Lancashire School of Health and Postgraduate Medicine, University of Central Lancashire</s1>
<s2>Preston, Lancashire</s2>
<s3>GBR</s3>
<sZ>3 aut.</sZ>
</fA14>
<fA20><s1>1868-1874</s1>
</fA20>
<fA21><s1>2007</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>2701</s2>
<s5>354000143480080300</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2007 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>25 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>07-0473188</s0>
</fA47>
<fA60><s1>P</s1>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Cancer</s0>
</fA64>
<fA66 i1="01"><s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>BACKGROUND. Obesity is considered a risk factor for the development of breast cancer-related lymphedema of the arm and as a poor prognostic factor in response to lymphedema treatment. The objective of this study was to examine weight reduction as a treatment for breast cancer-related lymphedema. METHODS. Twenty-one women with breast cancer-related lymphedema were randomized either to receive dietary advice for weight reduction or to receive a booklet on general healthy eating. They were monitored for 12 weeks. RESULTS. The primary outcome measure was arm volume at 12 weeks. The results indicated a significant reduction in swollen arm volume at the end of the 12-week period (P =.003) in the intervention weight-reduction group. There was a significant reduction in body weight (P =.02) and body mass index (P =.016) in the weight-reduction group at the end of the 12-week study period. CONCLUSIONS. Weight loss achieved by dietary advice to reduce energy intake can reduce breast cancer-related lymphedema significantly.</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002B04</s0>
</fC02>
<fC02 i1="02" i2="X"><s0>002B20E02</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Lymphoedème</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Lymphedema</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Linfedema</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Poids</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Weight</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Peso</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Traitement</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Treatment</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Tratamiento</s0>
<s5>03</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Régime alimentaire</s0>
<s5>05</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Diet</s0>
<s5>05</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Régimen alimentario</s0>
<s5>05</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Nutrition</s0>
<s5>06</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Nutrition</s0>
<s5>06</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Nutrición</s0>
<s5>06</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Cancérologie</s0>
<s5>08</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>Cancerology</s0>
<s5>08</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Cancerología</s0>
<s5>08</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE"><s0>Essai randomisé contrôlé</s0>
<s4>CD</s4>
<s5>96</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG"><s0>Randomised controlled trial</s0>
<s4>CD</s4>
<s5>96</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA"><s0>Ensayo clínico aleatorio</s0>
<s4>CD</s4>
<s5>96</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE"><s0>Cancer du sein</s0>
<s4>CD</s4>
<s5>97</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG"><s0>Breast cancer</s0>
<s4>CD</s4>
<s5>97</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA"><s0>Cáncer de pecho</s0>
<s4>CD</s4>
<s5>97</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Tumeur maligne</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Malignant tumor</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Tumor maligno</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Glande mammaire pathologie</s0>
<s2>NM</s2>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Mammary gland diseases</s0>
<s2>NM</s2>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Glándula mamaria patología</s0>
<s2>NM</s2>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Appareil circulatoire pathologie</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Cardiovascular disease</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Aparato circulatorio patología</s0>
<s5>39</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Lymphatique pathologie</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Lymphatic vessel disease</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Linfático patología</s0>
<s5>40</s5>
</fC07>
<fC07 i1="05" i2="X" l="FRE"><s0>Alimentation</s0>
<s5>41</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG"><s0>Feeding</s0>
<s5>41</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA"><s0>Alimentación</s0>
<s5>41</s5>
</fC07>
<fN21><s1>309</s1>
</fN21>
<fN44 i1="01"><s1>OTO</s1>
</fN44>
<fN82><s1>OTO</s1>
</fN82>
</pA>
</standard>
</inist>
<affiliations><list><country><li>Royaume-Uni</li>
</country>
<region><li>Angleterre</li>
<li>Grand Londres</li>
</region>
<settlement><li>Londres</li>
</settlement>
<orgName><li>Université de Londres</li>
</orgName>
</list>
<tree><country name="Royaume-Uni"><region name="Angleterre"><name sortKey="Shaw, Clare" sort="Shaw, Clare" uniqKey="Shaw C" first="Clare" last="Shaw">Clare Shaw</name>
</region>
<name sortKey="Judd, Patricia A" sort="Judd, Patricia A" uniqKey="Judd P" first="Patricia A." last="Judd">Patricia A. Judd</name>
<name sortKey="Mortimer, Peter" sort="Mortimer, Peter" uniqKey="Mortimer P" first="Peter" last="Mortimer">Peter Mortimer (dermatologue)</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PascalFrancis/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000486 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Checkpoint/biblio.hfd -nk 000486 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= LymphedemaV1 |flux= PascalFrancis |étape= Checkpoint |type= RBID |clé= Pascal:07-0473188 |texte= A randomized controlled trial of weight reduction as a treatment for breast cancer-related lymphedema }}
This area was generated with Dilib version V0.6.31. |